Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Total share-based compensation Share-based compensation Share-Based Payment Arrangement, Noncash Expense ADSs [Member] Basic and Diluted Net Loss Per Share (Details) [Table] Preferred Shares [Member] Preferred Shares Member Schedule of Number of Shares and Loss Used in the Computation of Net Loss Per Share [Abstract] Net loss attributable to equity holders of the Company Net profit (loss) Net profit (loss) Net profit (loss) Net Income (Loss) Attributable to Parent Award Type [Domain] Warrants [Member] Warrants Member Diluted weighted average number of shares outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted Share Units [Member] Restricted Stock [Member] Weighted number of shares Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, basic (in Shares) Weighted Average Number of Shares Outstanding, Basic Basic and Diluted Net Loss Per Share [Line Items] Share Option [Member] Share Option Member Basic and Diluted Net Loss Per Share [Abstract] Award Type [Axis] Shares issued Issuance of ordinary shares (in Shares) Stock Issued During Period, Shares, New Issues Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Ordinary shares Class of Stock [Axis] Class of Stock [Domain] Scenario [Axis] Scenario [Domain] Forecast [Member] Schedule Of Recognized Revenue From Contracts With Customers Abstract Schedule of Disaggregated by the Geographic Location [Line Items] Schedule of Recognized Revenue from Contracts with Customers [Line Items] Disaggregation of Revenue [Table] Revenue from contracts with customers Revenues Revenues Aggregate amount Aggregate amount. Cash Sale of ADS Sale of American Depositary Shares Sale of american depositary shares. Description of CODM Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description SHAREHOLDERS’ EQUITY: Equity, Attributable to Parent [Abstract] Preferred shares, no par value; Authorized: 1,000 shares at June 30, 2026 and 1,000 shares at December 31, 2025 (redemption amount of $34,000); Issued and outstanding: 1,000 shares at June 30, 2026 and 1,000 shares at December 31, 2025. Preferred Stock, Value, Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Total shareholders’ equity Balance Balance Equity, Attributable to Parent Ordinary shares of no par value (in Dollars per share) Common Stock, No Par Value Ordinary shares, issued Common Stock, Shares, Issued Preferred shares, par value (in Dollars per share) Preferred Stock, No Par Value Preferred shares, issued Preferred Stock, Shares Issued Total operating expenses Operating Expenses Total Financial Income (Expenses) net, Financial expenses (income), net Nonoperating Income (Expense) Net loss per share attributable to ordinary shareholders, basic (in Dollars per share) Earnings Per Share, Basic Additional paid-in capital Additional Paid-in Capital [Member] Ordinary shares, outstanding Common Stock, Shares, Outstanding Operating lease right-of-use assets Business Combination Recognized Asset Acquired Operating Lease Right-of-Use Assets Represent the amount of operating lease right-of-use assets. CURRENT ASSETS: Assets, Current [Abstract] Restricted cash Restricted Cash, Current Trade receivables Accounts Receivable, after Allowance for Credit Loss, Current NON-CURRENT ASSETS: Assets, Noncurrent [Abstract] Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Exercise of prefunded warrants (in Shares) Stock Issued During Period Shares Exercise Of Prefunded Warrant Number of shares issued during the period as a exercise of prefunded warrant. Preferred shares, redemption amount (in Dollars) Preferred Shares Redemption Amount The amount of preferred shares redemption amount. Income Statement [Abstract] Cost of revenues Cost of Revenue Research and development expenses, net Total research and development expenses Research and development Research and Development Expense Statement of Financial Position [Abstract] Cash and cash equivalents Cash and Cash Equivalent Prepaid expenses and other receivables Prepaid Expense and Other Assets, Current Total current assets Assets, Current Exercise of prefunded warrants Stock Issued During Period Value Exercise Of Prefunded Warrants Represents the amount of exercise of prefunded warrants. Gain from bargain purchase Gain from bargain purchase Gain from bargain purchase Represents the amount of gain from bargain purchase. Schedule of Preliminary Allocation of the Purchase Price [Abstract] Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Trade receivables Business Combination, Recognized Asset Acquired, Receivable, Current Other receivables Business Combination, Recognized Asset Acquired, Other Receivable, Current Amount of other receivables acquired in business combination and recognized at acquisition date, classified as current. Includes, but is not limited to, receivable from customer for product and service. Property and equipment Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment, Total Trade payables Business Combination, Recognized Liability Assumed, Accounts Payable, Current Other payables Business Combination, Recognized Liability Assumed, Other Accounts Payable, Current Amount of other accounts payable assumed in business combination and recognized at acquisition date, classified as current. Operating lease liabilities Business Combination, Recognized Liability Assumed, Operating Lease Liability Amount of operating lease liability assumed in business combination and recognized at acquisition date. Net identifiable assets acquired Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), Total CONTINGENT LIABILITIES AND COMMITMENTS Commitments and Contingencies Ordinary shares of no par value: Authorized: 1,600,000,000,000 shares at June 30, 2026 and at December 31, 2025; Issued and outstanding 22,800,887,584, shares at June 30, 2026 and 13,872,899,584 shares at December 31, 2025 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total liabilities and shareholders’ equity Liabilities and Equity Ordinary shares, authorized Common Stock, Shares Authorized Preferred shares, authorized Preferred Stock, Shares Authorized Total operating profit (loss) Segment operational loss Operating Income (Loss) Net loss per share attributable to ordinary shareholders, diluted (in Dollars per share) Earnings Per Share, Diluted PinCell’s [Member] Aggregate purchase price per share Aggregate purchase price per share. Percentage of issued and outstanding share capital Percentage of issued and outstanding share capital. Share Purchase Agreement [Member] Recipharm Israel Ltd. [Member] Royalties percentage Royalties Percentage Percentage of royalties. Gross proceeds percentage Gross Proceeds Percentage Gross proceeds percentage. Conditions of the agreement Conditions of the agreement. Issuance related costs Payment of Financing and Stock Issuance Costs, Total Aggregate gross proceeds Proceeds from Sale of Equity Method Investments Percentage was satisfied upon execution Percentage was satisfied upon execution. Percentage of remaining payable in cash Percentage of remaining payable in cash. Percentage of the lowest daily volume weighted average price Percentage of the lowest daily volume weighted average price. YA [Member] Commitment fee Commitment fee Outstanding Commitment Fee Represent the amount of outstanding commitment fee. EIB Restructuring Transaction [Member] EIBLoan Member Statement [Table] Accumulated equity (deficit) Retained Earnings [Member] Commercial sales exceeding Commercial Sales Exceeding The value of commercial sales exceeding. Loan from Others [Abstract] SHAREHOLDERS' EQUITY Equity [Text Block] Share-Based Compensation [Abstract] BASIC AND DILUTED NET LOSS PER SHARE Earnings Per Share [Text Block] REVENUES Revenue from Contract with Customer [Text Block] Segments [Abstract] Schedule of Significant Expense Categories and Other Segment Segment Reporting, Reconciliation of Revenue by Segment to Consolidated [Table Text Block] Segment Reporting [Table] Segment Reporting [Line Items] Revenues [Abstract] Cost of Revenue [Abstract] Research and Development Expense [Abstract] Subsegments [Axis] Subsegments [Domain] CDMO [Member] Contract Development and Manufacturing Organization [Member] Other [Member] Other [Member] Product and Service [Axis] Product and Service [Domain] External [Member] Cost of revenues [Member] Cost Of Revenues [Member] Commitments [Abstract] LOAN FROM OTHERS Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Shareholders’ Equity [Abstract] Vested RSU’s Stock Issued During Period, Value, Restricted Stock Award, Gross Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] General [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Remaining paid amount Payments of Stock Issuance Costs Option Agreement [Member] Development funding amount Research and Development Expense (Excluding Acquired in Process Cost) Development and expansion Development and expansion. Monthly payments on options Represents the amount of monthly payments on options. Proceeds from Issuance of Warrants Nominal consideration value Represents the amount of nominal consideration value. Statement of Stockholders' Equity [Abstract] Preferred shares Preferred Shares [Member] Preferred Stock [Member] Issuance of pre-funded warrants, net of issuance costs Stock Issued During Period, Value, Other COMMITMENTS Commitments and Contingencies Disclosure [Text Block] Loanfrom Others [Table] Debt Instrument [Axis] Risk-free rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Outstanding amount Long-Term Debt, Average Amount Outstanding Maturity date Debt Instrument, Maturity Date Statement of Comprehensive Income [Abstract] Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Total comprehensive profit (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Foreign currency translation adjustments Cumulative translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Agreement value Issuance of ordinary shares Stock Issued During Period, Value, New Issues Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] March 2025 SEPA [Member] September 2025 SEPA [Member] Percentage of commitment fee Revenue, Remaining Performance Obligation, Percentage YA II PN, Ltd [Member] Sale of ADS Issuance of shares Sale of Stock, Number of Shares Issued in Transaction Purchase price Sale of Stock, Consideration Received on Transaction Related and Nonrelated Parties [Axis] American Depositary Shares [Member] American Depositary Shares Member Original principal amount Principal Transactions Revenue, Net Expected term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term STD rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Shareholders' Equity (Details) [Table] Related and Nonrelated Parties [Domain] Marketing, general and administrative expenses [Member] Marketing General And Administrative Expenses [Member] Research and development expenses [Member] Research And Development Expenses [Member] Schedule of the Total Share-Based Compensation Expense Related to All of the Company’s Equity-Based Awards [Abstract] Statement Of Income Location [Axis] Statement Of Income Location [Domain] Schedule of Total Share-Based Compensation Expense to Equity-Based Awards [Line Items] Aggregate pre-funded warrant Purchase of warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Geographical [Axis] Geographical [Domain] Israel [Member] ISRAEL Outside Israel [Member] Subsequent Events [Abstract] Subsequent Event Type [Axis] Preferred shares, outstanding Preferred Stock, Shares Outstanding Gross profit (loss) Gross Profit Marketing, general, and administrative expenses Selling, General and Administrative Expense Subsequent Event [Table] Subsequent Event Type [Domain] Document Information [Table] Entity Central Index Key Entity Central Index Key Document Fiscal Year Focus Document Fiscal Year Focus Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Current Fiscal Year End Date Current Fiscal Year End Date Property, plant and equipment, net Property, Plant and Equipment, Net Total non-current assets Assets, Noncurrent CURRENT LIABILITIES: Liabilities, Current [Abstract] Operating lease liabilities Operating Lease, Liability, Current Total current liabilities Liabilities, Current Non-current operating lease liabilities Operating Lease, Liability, Noncurrent Shares conversion Stock Issued During Period, Shares, Conversion of Units Subsequent Event [Member] Subsequent Event [Member] Subsequent Events [Line Items] Cover [Abstract] Document Information [Line Items] Document Type Document Type Entity File Number Entity File Number Amendment Flag Amendment Flag Document Fiscal Period Focus Document Fiscal Period Focus Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Total assets Assets Trade payables Accounts Payable, Trade, Current Other payables Accounts Payable, Other, Current NON-CURRENT LIABILITIES: Liabilities, Noncurrent [Abstract] Loan from others Other Loans Payable, Long-Term, Noncurrent Total non-current liabilities Liabilities, Noncurrent Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Accumulated comprehensive loss AOCI Attributable to Parent [Member] Liability Other Liabilities Increase (decrease) in other payables Increase (Decrease) in Other Accounts Payable Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Restricted cash Restricted Cash GENERAL Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Summary of Significant Accounting Policies [Abstract] Shares issued for SEPA financing agreement Shares Issued For SEPAFinancing Agreement Shares issued for SEPA financing agreement. Incorporated date Entity Incorporation, Date of Incorporation Total consideration Business Combination, Consideration Transferred, Other Commitments (Details) [Table] Contingent Consideration Type [Domain] Statistical Measurement [Domain] Maximum [Member] Maximum [Member] Grants received Grants Receivable Royalty amounts payable Royalty Expense SUBSEQUENT EVENTS Subsequent Events [Text Block] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Number of Shares and Loss Used in the Computation of Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Disaggregated by the Geographic Location Disaggregation of Revenue [Table Text Block] Statement [Line Items] Balance (in Shares) Balance (in Shares) Shares, Outstanding Acquired business contributed revenues Business Combination, Acquiree's Revenue, Prior Period Acquired business contributed net loss Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual Business Combination [Axis] Business Combination [Domain] Business Combination [Member] Business Combination, Series of Individually Immaterial Business Combinations [Member] Accrued interest Accrued Royalties Non-dilutive grant fund amount Represent the amount of non dilutive grant fund. Additional cancellation fee payable Represent the amount of additional cancellation fee payable. Non-cash transactions: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Reconciliation of cash, cash equivalents and restricted cash: Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract] Cash received in business combination Cash Acquired from Acquisition Other payables Other Notes Payable, Current Percentage of share capital and voting rights Percentage Of Share Capital And Voting Rights Percentage of share capital and voting rights. Operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Financial expense (income) related to loan from others Financial Expense Related To Loan From Others Amount of financial expense related to loan from others. Decrease (increase) in other receivables Increase (Decrease) in Accounts and Other Receivables SEPA commitment fees Debt Related Commitment Fees and Debt Issuance Costs Increase in trade payables Increase (Decrease) in Accounts Payable, Trade General [Abstract] Diluted share capital Percentage Of Diluted Share Capital Percentage of diluted share capital. Contingent Consideration by Type [Axis] Israeli Innovation Authority (IIA) [Member] Israeli Innovation Authority IIAMember Statistical Measurement [Axis] Minimum [Member] Minimum [Member] Commitments [Line Items] SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] SEGMENTS Segment Reporting Disclosure [Text Block] Basis of Presentation Basis of Presentation and Significant Accounting Policies [Text Block] Schedule of the Total Share-Based Compensation Expense Related to All of the Company’s Equity-Based Awards Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Issuance of pre-funded warrants, net of issuance costs (in Shares) Stock Issued During Period, Shares, Other Vested RSU’s (in Shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Statement of Cash Flows [Abstract] Depreciation of property, plant and equipment Depreciation, Depletion and Amortization, Nonproduction Decrease (increase) in trade receivables Increase (Decrease) in Accounts Receivable Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect Of Exchange Rate Changes On Cash Cash Equivalents And Restricted Cash Effect of exchange rate changes on cash, cash equivalents and restricted cash. Changes in operating lease right-of-use assets Increase (Decrease) in Other Operating Assets Changes in operating lease liabilities Increase (Decrease) in Operating Lease Liability Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from issuance of ordinary shares for SEPA holders, net Proceeds from Issuance of Common Stock Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Shareholders’ Equity [Line Items] Plan Name [Axis] 2005 Israeli Share Option Plan [Member] Two Thousand Five Israeli Share Option Plan Member Share-Based Compensation [Line Items] Vested term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Grant fair value (in Dollars) Share Based Compensation Arrangement By Share Based Payment Award Granted Fair Value Represent the amount of granted fair value. Recognized over a period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Purchase agreement percentage Purchase Agreement Percentage Purchase agreement percentage. Gross proceeds Proceeds from Issuance of Debt Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Plan Name [Domain] 2018 Israeli Share Option Plan [Member] Two Thousand Eighteen Israeli Share Option Plan Member RSU [Member] Restricted Stock Units (RSUs) [Member] Exercisable grant term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Shares granted (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Unrecognized costs related to share based compensation (in Dollars) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Finance costs Debt Issuance Costs, Gross Minimum acceptable price per share Sale of Stock, Price Per Share Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Series A Warrants [Member] Series B Warrants [Member] Exercisable term Class of Warrant or Right, Exercisable Term Term of class of warrant or right, exercisable. Warrant Inducement Agreement [Member] Warrant inducement transaction Proceeds from Issuance of Private Placement Debt Instrument, Name [Domain] Loan from Others [Line Items]